Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jan 15;16(1):1.
doi: 10.1186/s12970-019-0268-9.

Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms

Affiliations
Randomized Controlled Trial

Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms

Melanie Wiffin et al. J Int Soc Sports Nutr. .

Abstract

Background: Research has demonstrated that low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diets improve gastrointestinal (GI) symptoms in irritable bowel syndrome sufferers. Exercise-related GI issues are a common cause of underperformance, with current evidence focusing on the use of FODMAP approaches with recreationally competitive or highly trained athletes. However, there is a paucity of research exploring the potential benefit of FODMAP strategies to support healthy, recreational athletes who experience GI issues during training. This study therefore aimed to assess whether a short-term LOWFODMAP diet improved exercise-related GI symptoms and the perceived ability to exercise in recreational runners.

Methods: Sixteen healthy volunteers were randomly assigned in a crossover design manner to either a LOWFODMAP (16.06 ± 1.79 g·d- 1) or HIGHFODMAP (38.65 ± 6.66 g·d- 1) diet for 7 days, with a one week washout period followed by a further 7 days on the alternate diet. Participants rated their gastrointestinal symptoms on an adapted version of the Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) questionnaire before and at the end of each dietary period. Perceived ability to exercise (frequency, intensity and duration) in relation to each dietary period was also rated using a visual analogue scale. Resting blood samples were collected prior to and on completion of each diet to determine plasma intestinal fatty acid binding protein (I-FABP) as a marker of acute GI injury.

Results: Overall IBS-SSS score significantly reduced in the LOWFODMAP condition from 81.1 ± 16.4 to 31.3 ± 9.2 (arbitrary units; P = 0.004). Perceived exercise frequency (z = 2.309, P = 0.02) and intensity (z = 2.687, P = 0.007) was significantly improved following a short-term LOWFODMAP approach compared to HIGHFODMAP. No significant differences were reported between dietary conditions for plasma I-FABP (P > 0.05).

Conclusions: A short-term LOWFODMAP diet under free-living conditions reduced exercise-related GI symptoms and improved the perceived ability to exercise in otherwise healthy, recreational runners. These findings may be explained by a reduction in indigestible carbohydrates available for fermentation in the gut. The therapeutic benefits of LOWFODMAP diets in recreational and trained athletes during sustained training periods warrants further investigation.

Keywords: FODMAP diet; Gastrointestinal symptoms; Nutrition; Recreational athletes.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Faculty of Science and Technology Ethics Committee, Anglia Ruskin University (FST/FREP/15/567).Written informed consent was obtained from all individual participants included in the study.

Consent for publication

As part of the written informed consent procedure, all participants were duly made aware (as part of both the study briefing and information sheet) that the study results may be published. As such, consent for publication was included as part of this process.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Participant GI symptom scores following each dietary intervention. Displays individual participant accumulated IBS-symptom severity scores following each FODMAP condition. Au = arbitrary units. * denotes significant difference pre-post within group (P = 0.004); ** denotes significant difference between dietary conditions (post; P = 0.007)
Fig. 2
Fig. 2
Relative changes in mean GI symptom responses following each dietary condition. The figure demonstrates the mean delta change in GI responses following each FODMAP condition. Au = arbitrary units. * denotes significant difference between conditions (P = 0.02)
Fig. 3
Fig. 3
Mean plasma I-FABP concentrations at rest in response to FODMAP conditions. The figure demonstrates the average I-FABP (pg·ml− 1) before and after the LOWFODMAP and HIGHFODMAP intervention. No significant differences reported (P > 0.05)

References

    1. Blakemore SJ, Aledo JC, James J, Campbell FC, Lucocq JM, Hundal HS. The GLUT5 hexose transporter is also localized to the basolateral membrane of the human jejunum. Biochem J. 1995;309(1):7–12. doi: 10.1042/bj3090007. - DOI - PMC - PubMed
    1. Jones HF, Butler RN, Brooks DA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastro Liver Physiol. 2011;300(2):202–206. doi: 10.1152/ajpgi.00457.2010. - DOI - PubMed
    1. Fujisawa T, Mulligan K, Wada L, Schumacher L, Riby J, Kretchmer N. The effect of exercise on fructose absorption. Am J Clin Nutr. 1993;58:75–79. doi: 10.1093/ajcn/58.1.75. - DOI - PubMed
    1. Rowlands DS, Swift M, Ros M, Green JG. Composite versus single transportable carbohydrate solution enhances race and laboratory cycling performance. Appl Physiol Nutr Metab. 2012;37(3):425–436. doi: 10.1139/h2012-013. - DOI - PubMed
    1. Barrett JS. Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutr in Clin Prac. 2013;28(3):300–306. doi: 10.1177/0884533613485790. - DOI - PubMed

Publication types